Spineology commenced the full market release of the Elite™ Expandable Interbody Fusion System. More than 300 cases have been completed since limited launch in 2Q16.
In 1Q17, FDA expanded clearance for the system to include a narrower 10mm footprint and allograft bone labeling that allows its use with Incite™ Cortical Fibers.
Spineology commenced the full market release of the Elite™ Expandable Interbody Fusion System. More than 300 cases have been completed since limited launch in 2Q16.
In 1Q17, FDA expanded clearance for the system to include a narrower 10mm footprint and allograft bone labeling that allows its use with Incite™ Cortical Fibers.
Sources:...
Image courtesy of Spineology Inc.
Spineology commenced the full market release of the Elite™ Expandable Interbody Fusion System. More than 300 cases have been completed since limited launch in 2Q16.
In 1Q17, FDA expanded clearance for the system to include a narrower 10mm footprint and allograft bone labeling that allows its use with Incite™ Cortical Fibers.
Copy to clipboard 
